logo

Aerovate Therapeutics Inc (AVTE) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Aerovate Therapeutics Inc’s current trading price is -92.04% away from its 52-week high, while its distance from the 52-week low is 106.40%. The stock’s price range over this period has fluctuated between $1.25 and $32.42. The company, operating within the financial sector, had a trading volume of approximately 0.25 million for the day, which was noticeably lower than the average daily share volume of 0.8 million over the last 3 months.

Aerovate Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $32.42 on 04/01/24 and the lowest value was $1.25 on 06/20/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Aerovate Therapeutics Inc (AVTE) has experienced a quarterly rise of 9.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 74.50M and boasts a workforce of 51 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.34, with a change in price of +0.71. Similarly, Aerovate Therapeutics Inc recorded 578,541 in trading volume during the last 100 days, posting a change of +37.97%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AVTE stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

AVTE Stock Stochastic Average

Today’s raw stochastic average for Aerovate Therapeutics Inc over the last 50 days is 38.71%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 54.55%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 25.12% and 16.58%, respectively.

AVTE Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -2.64% this year. Over the last six months, there has been a weaker performance of 41.76%. The price of AVTE fallen by 0.78% during the last 30 days period. For the last 5-days stocks have improved 1.18%.

Most Popular